Malaria remains the most prevalent, with an estimated 249 million cases in 2022. Other major targets include Chagas disease, leishmaniasis, giardiasis, and trichomoniasis.
The global antiprotozoal drugs market is experiencing significant growth, driven by the rising burden of diseases like malaria and leishmaniasis. antiprotozoal drug
Compounds such as Metronidazole , Atovaquone, and Benznidazole continue to lead treatment protocols. Malaria remains the most prevalent, with an estimated
Antiprotozoal drugs are a class of medications specifically designed to treat infections caused by protozoa—single-celled eukaryotic organisms. These drugs are critical for managing diseases that primarily affect tropical and subtropical regions, impacting over annually. Market and Clinical Landscape Malaria remains the most prevalent
Antiprotozoals are often categorized into and other antiprotozoal drugs .